- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 25.48M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 17.73M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 8.36M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $0 |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$3.81M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.78M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $3.11M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.51M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $3.03M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $356.74K |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $6.14M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $8.53M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.61M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $3.72M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $3.8M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $3.14M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $4.64M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.08M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.12 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.64 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.12 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.64 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.48M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $2.18M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $1.93M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $2.65M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.15M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$5.34M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$3.39M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$4.81M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $15.79K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $22.09K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $7.39K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $2.91K |
| Revenue | Q1 2026 · Mar 31, 2026 | $23.17K |
| Revenue | Q1 2026 · Mar 31, 2025 | $25K |
| Capex | Q1 2026 · Mar 31, 2025 | $36.4K |